Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
about
Conditional immortalization of human B cells by CD40 ligation.Cystatin E/M suppresses legumain activity and invasion of human melanomaDirect T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity.A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes.MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportCytotoxic T lymphocyte responses against melanocytes and melanoma.Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma modelHDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition.Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytesFrequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes.Functional heterogeneity of vaccine-induced CD8(+) T cells.Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitroEnhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan ATargeting T cells with bispecific antibodies for cancer therapyEffect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells.Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma.A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
P2860
Q33316020-2300B54B-04CE-4CA3-9689-4A55BEFAF22DQ33523914-A4418A94-9DDB-4128-B956-F1F8E71ACC35Q33750137-C920CE2F-DFB0-438B-8B1E-C484E7CF0424Q33979895-D7901BA8-0189-4EF9-833B-5E226DA9F352Q34063596-656C7A62-5662-48B9-ACB0-D59C8D79C2D0Q34245409-D0095944-19E0-4568-81FE-9716C85BE545Q34669336-25D28844-9453-4756-9D2F-21B4C164705BQ35172610-75F00525-F3EB-4F63-93B9-663EC09A1453Q35184110-4D1CDD04-F691-4D8B-A54F-677C68F020C1Q36131100-1E1D9592-0CA5-4C12-8894-2978ED744F88Q36359485-A7FD7506-FB93-4967-B1AD-A85AD2C30774Q36375095-4CEE2884-072C-4240-B0E5-339532098D18Q36423969-F3E84C14-FA03-4B8D-B9B1-8F8678618CD3Q36431400-FE9B9E22-6C1B-4581-A59F-523E045A64D1Q36431817-310CF77B-0E64-4C69-AC6B-CB14232A2AF0Q36432030-049166E3-8F02-49D5-ABEC-DA8193B5E135Q36621391-70253D83-88F5-4EB6-9BF1-998F31F55251Q36835348-AFFAAFA4-385A-4489-8D7C-6AB172249C62Q36908627-C756A5DC-C339-4D70-AE5C-825B43DA9E65Q36924579-C045EDF9-50FC-4DFD-BBBE-D5DC8C077613Q37003339-CC9A87C0-E85A-4FF5-A181-E75305B93FAAQ37220742-F977FA56-FB15-4C55-97B6-52BC970FE641Q37244329-32FCF894-806A-4DBE-8B52-2A3BE5D388F8Q37334596-B84A4DC4-07DA-4279-83AD-EFDDEBA085F4Q37383437-DE371B1E-6B48-4F3A-BA96-6E43F44EBC87Q37390973-ED59A64F-D20B-4413-80CD-9DEE8437D0E2Q38049494-C237DF91-0C5C-4622-B046-497B85CACF17Q41783600-79DCEAB9-42DF-4B91-853A-12EB6701BCCBQ42126236-115B3923-968B-4747-8E16-3848DF17F0DDQ42136462-4DF46553-C29D-4D46-B058-4561DA342BB8Q42697252-EE1CA7D1-D325-4F16-A849-D738226243CA
P2860
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@ast
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@en
type
label
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@ast
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@en
prefLabel
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@ast
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@en
P2093
P2860
P1433
P1476
Quantitative correlation betwe ...... cific cytotoxic T lymphocytes.
@en
P2093
K C Barracchini
L Rivoltini
N P Restifo
S A Rosenberg
S L Topalian
T B Simonis
V Viggiano
Y Kawakami
P2860
P304
P407
P577
1995-07-01T00:00:00Z